Screener
Exelixis EXEL Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Exelixis’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0000939767-26-000098
FAQ
- What is Exelixis's cash & equivalents?
- Exelixis (EXEL) reported cash & equivalents of $281.45M in Q2 2026.
- How has Exelixis's cash & equivalents changed year-over-year?
- Exelixis's cash & equivalents increased by 71.2% year-over-year, from $164.43M to $281.45M.
- What is the long-term trend for Exelixis's cash & equivalents?
- Over 5 years (2020 to 2025), Exelixis's cash & equivalents has grown at a 8.5% compound annual growth rate (CAGR), from $320.77M to $482.49M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Exelixis's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude